lobbying_activities: 1333102

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1333102	085941b9-a3d3-46da-b778-e1bb0df09022	Q4	VAN HEUVELEN STRATEGIES, LLC	321874	GENERIC PHARMACEUTICAL ASSOCIATION	2012	fourth_quarter	CSP	Prescription drug user fee act and other issues related to generic drugs; Generic Drug User Fee Act, S.3187 Food and Drug Administration Safety and Innovation Act, S.2295 the Patient Safety and Generic Labeling Improvement Act, issues related to patent settlements; H.R.6433, FDA User Fee Corrections Act of 2012.	HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2013-01-11T15:36:28.543000-05:00